Home › NDC Lookup › Ingredients › Benazepril Hydrochloride › 65862-0118-01
⚪image loading
(from DailyMed)

Benazepril Hydrochloride 40 mg Tablet, Film Coated, 100-count — NDC 65862-118-01 (Billing 65862-0118-01)

by Aurobindo Pharma Limited · 100 TABLET, FILM COATED in 1 BOTTLE

This is a package of 100 tablets of Benazepril Hydrochloride 40 mg Tablet, Film Coated from Aurobindo Pharma Limited, marketed since May 2008 and currently FDA-listed; retail pharmacies pay about $0.1011 per tablet (NADAC). It is the main listing for this product, which comes in 3 package sizes.

NDC 65862-0118-01
🏷️ FDA NDC (as labeled) 65862-118-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.1011 NADAC Per package$10.11 / 100 tablets Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.2827/unit · Part D plans $0.1207/unit — full pricing hub ↓
Main listing for product 65862-118 · Also comes in: 90 tablets 65862-118-90 6000 tablets 65862-118-61
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65862-118-01 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
65862 labeler · 118 product · 01 package
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6586211801 1
Medicaid fills, this package
3,438 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65862-118-01
Product NDC 65862-118
11-digit billing NDC 65862011801
NCPDP billing unit EA — each (per item)
SPL Set ID 71e185df-48b7-43ec-8c02-a0df59099c54
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2008-05-22
Marketing end 2026-11-30
Dosage form TABLET, FILM COATED
Substance BENAZEPRIL HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 36100005100340
GPI class Benazepril HCl
GCN Seq No 016042
GCN 48614
HICL code 006113
Ingredient (HICL) Benazepril Hcl
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A4
Therapeutic class — intermediate (HIC2) Antihypertensives
HIC3 code A4D
Therapeutic class — specific (HIC3) Antihypertensives, Ace Inhibitors
AHFS code 24:32.04.00
AHFS class Angiotensin-Converting Enzyme Inhibitors
FDB label name BENAZEPRIL HCL 40 MG TABLET
FDB brand name Benazepril Hcl
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 016042
  • GCN: 48614
  • GPI-14 (Medi-Span): 36100005100340
  • HICL (First Databank): 006113
  • AHFS class code: 24:32.04.00
Why two NDCs? The FDA registers this code as 65862-118-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65862-0118-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name BENAZEPRIL HCL 40 MG TABLET Ingredient Benazepril Hcl
📖 What it is MedlinePlus · NLM

Benazepril is used alone or in combination with other medications to treat high blood pressure. Benazepril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In additi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Benazepril is used to treat high blood pressure (hypertension). By relaxing your blood vessels, it brings your numbers down — and that directly lowers your risk of serious events l...
  • Not everyone does, but a dry, persistent cough is one of the most well-known side effects of ACE inhibitors like benazepril. It's not dangerous, but it can be annoying enough that...
  • I keep hearing about a cough with this type of medicine. Will I definitely get one?
  • No — benazepril is not safe during pregnancy. It carries a serious warning: it can harm or even kill an unborn baby, especially in the second and third trimesters. If you find out...
📖 Read our full Benazepril guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Benazepril may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Benazepril nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.101 $10.11 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.2827 $28.27 / 100 tablets
Medicare drug plans payPart D · Q2 2026 $0.1207 $12.07 / 100 tablets
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.129 $0.090
▼ Down 22% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
65862-0118-01 You're viewing this Main listing 100 TABLET, FILM COATED in 1 BOTTLE $0.1011 / ea $10.11 2008-05-22 — Active
65862-0118-90 65862-118-90 90 TABLET, FILM COATED in 1 BOTTLE — — 2008-05-22 — Discontinued by firm
65862-0118-61 65862-118-61 6000 TABLET, FILM COATED in 1 BAG — — — — Active

You're viewing one of 3 pack sizes for this product.

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet, film coated in 1 bottle.
How does this package differ from NDC 65862-0118-90?
Both are Benazepril Hydrochloride 40 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 100-count one, while NDC 65862-0118-90 is the 90 tablets package.
What NDC number is used to bill for this package of Benazepril Hydrochloride 40 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Benazepril Hydrochloride 40 mg 23155-0752-01 Heritage 100 tablets $0.101 AB Availability likely —
Benazepril Hydrochloride 40 mg 43547-0338-03 Solco 30 tablets $0.101 AB Availability likely —
Benazepril Hydrochloride 40 mg 50268-0112-15 AvPAK 50 tablets $0.101 AB Availability likely —
Benazepril Hydrochloride 40 mg 53746-0754-01 Amneal 100 tablets $0.101 AB Availability likely —
Benazepril hydrochloride 40 mg 62135-0722-90 Chartwell 90 tablets $0.101 AB Availability likely —
Benazepril Hydrochloride 40 mgthis 65862-0118-01 Aurobindo 100 tablets $0.101 — Availability likely —
Lotensin 40 mg 30698-0450-01 Validus 100 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 43063-0748-30 PD-Rx 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 50090-0914-00 A-S 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 50090-3359-00 A-S 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 51407-0465-01 Golden 100 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 51655-0617-26 Northwind 90 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 63187-0906-30 Proficient 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 65162-0754-03 Amneal 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 68071-1770-01 NuCare 100 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 68071-4722-09 NuCare 90 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 68071-5028-01 NuCare 100 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 68788-6957-01 Preferred 100 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 70518-2125-00 REMEDYREPACK 90 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 71205-0320-30 Proficient 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 71335-0267-01 Bryant 30 tablets — AB Discontinued —
Benazepril Hydrochloride 40 mg 71335-1365-01 Bryant 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 82868-0089-30 Northwind 30 tablets — AB FDA listed —
Benazepril Hydrochloride 40 mg 84386-0102-01 Aurobindo 100 tablets — — FDA listed —
Benazepril Hydrochloride 40 mg 62559-0527-01 ANI 100 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2008
On the market since
May 2008
📍
2026
Currently FDA-listed
18 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Benazepril inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code65862
First marketedMay 2008
Product typeDrug For Further Processing
Portfolio1,464 products on file

More NDCs from Aurobindo Pharma Limited labeler code 65862

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
3.4K
Units reimbursed last 4 qtrs
152.8K
Gross reimbursed last 4 qtrs
$43.2K
Avg / prescription
$12.57
Avg / unit
$0.2827
Latest quarter Q1 2026
259Rx
Medicaid pays / ea
$0.2827
gross reimbursed
vs
NADAC / ea
$0.1011
acquisition cost
=
Spread
+$0.1816
+180% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
55% FFS 45% MCO
Fee-for-service · 1,896 Rx Managed care · 1,542 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 3,587 units · 45.9 per 100k residents WA Idaho: 636 units · 32.4 per 100k residents ID Montana: 570 units · 50.4 per 100k residents MT North Dakota: no data reported ND Minnesota: 1,014 units · 17.7 per 100k residents MN Wisconsin: 4,746 units · 80.3 per 100k residents WI Michigan: 3,174 units · 31.6 per 100k residents MI New York: 42,475 units · 217 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 2,760 units · 65.2 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 1,517 units · 47.3 per 100k residents IA Illinois: 5,518 units · 44.0 per 100k residents IL Indiana: 810 units · 11.8 per 100k residents IN Ohio: 2,444 units · 20.7 per 100k residents OH Pennsylvania: 6,089 units · 47.0 per 100k residents PA New Jersey: 7,862 units · 84.6 per 100k residents NJ Massachusetts: no data reported MA California: 34,455 units · 88.4 per 100k residents CA Utah: no data reported UT Colorado: 780 units · 13.3 per 100k residents CO Nebraska: 1,007 units · 50.9 per 100k residents NE Missouri: 2,825 units · 45.6 per 100k residents MO Kentucky: 5,712 units · 126 per 100k residents KY West Virginia: 2,267 units · 128 per 100k residents WV Virginia: 1,165 units · 13.4 per 100k residents VA Maryland: 1,740 units · 28.2 per 100k residents MD Connecticut: 1,318 units · 36.4 per 100k residents CT Rhode Island: no data reported RI Arizona: 1,132 units · 15.2 per 100k residents AZ New Mexico: no data reported NM Kansas: 256 units · 8.7 per 100k residents KS Arkansas: 675 units · 22.0 per 100k residents AR Tennessee: 3,009 units · 42.2 per 100k residents TN North Carolina: 2,172 units · 20.0 per 100k residents NC South Carolina: 1,228 units · 22.9 per 100k residents SC Delaware: no data reported DE Oklahoma: 580 units · 14.3 per 100k residents OK Louisiana: 3,376 units · 73.8 per 100k residents LA Mississippi: 390 units · 13.3 per 100k residents MS Alabama: 750 units · 14.7 per 100k residents AL Georgia: 838 units · 7.6 per 100k residents GA D.C.: 970 units · 143 per 100k residents DC Hawaii: no data reported HI Texas: 1,621 units · 5.3 per 100k residents TX Florida: 1,377 units · 6.1 per 100k residents FL
Units reimbursed · per 100k residents
5.3217
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 217 /100k
2 D.C. 143 /100k
3 West Virginia 128 /100k
4 Kentucky 126 /100k
5 California 88.4 /100k
6 New Jersey 84.6 /100k
7 Wisconsin 80.3 /100k
8 Louisiana 73.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 tablets this page65862-0118-01 3,438 Rx · $43,206
90 tablets65862-0118-90 No Medicaid data
6000 tablets65862-0118-61 No Medicaid data
Drug total (last 4 qtrs): 3,438 Rx · 152,845 units · $43,206 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Aurobindo Pharma Limited has reported a marketing end date of 2026-11-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 90 tablets (65862-0118-90), 6000 tablets (65862-0118-61). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65862-0117-01 · Aurobindo 65862-0125-01 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.